Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Chia

Showing results (91-100 of 104) with videos related to

Pageof 11
Sort By:
Therapeutic Advances in Medical Oncology|June 5, 2023
Rationale and trial design of NATALEE: a Phase III trial of adjuvant ribociclib + endocrine therapy Dennis J Slamon, Peter A Fasching, Sara Hurvitz, et al.
Cell|December 4, 2003
EMSY links the BRCA2 pathway to sporadic breast and ovarian cancerLuke Hughes-Davies, David Huntsman, Margarida Ruas, et al.
JNCI Cancer Spectrum|November 2, 2020
Establishing a Framework for the Clinical Translation of Germline Findings in Precision OncologyKatherine Dixon, Sean Young, Yaoqing Shen, et al.
The Lancet. Oncology|July 13, 2026
Switching to camizestrant at ESR1 mutation emergence before disease progression during first-line treatment of hormone receptor-positive advanced breast cancer (SERENA-6): extended analysis of a double-blind, placebo-controlled, randomised, phase 3 trialNicholas C Turner, Erica L Mayer, Yeon Hee Park, et al.
Cold Spring Harbor Molecular Case Studies|May 6, 2016
Lessons learned from the application of whole-genome analysis to the treatment of patients with advanced cancersJanessa Laskin, Steven Jones, Samuel Aparicio, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 7, 2020
Improved structural variant interpretation for hereditary cancer susceptibility using long-read sequencingMy Linh Thibodeau, Kieran O'Neill, Katherine Dixon, et al.
The New England Journal of Medicine|March 20, 2024
Ribociclib plus Endocrine Therapy in Early Breast CancerDennis Slamon, Oleg Lipatov, Zbigniew Nowecki, et al.
Clinical Breast Cancer|November 13, 2020
Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET TrialArlene Chan, Beverly Moy, Janine Mansi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2017
Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast CancerEric Y Zhao, Yaoqing Shen, Erin Pleasance, et al.
JAMA|April 2, 2024
Tumor-Infiltrating Lymphocytes in Triple-Negative Breast CancerRoberto A Leon-Ferre, Sarah Flora Jonas, Roberto Salgado, et al.
Pageof 11

Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
Therapeutic Advances in Medical Oncology|June 5, 2023
Rationale and trial design of NATALEE: a Phase III trial of adjuvant ribociclib + endocrine therapy Dennis J Slamon, Peter A Fasching, Sara Hurvitz, et al.
Cell|December 4, 2003
EMSY links the BRCA2 pathway to sporadic breast and ovarian cancerLuke Hughes-Davies, David Huntsman, Margarida Ruas, et al.
JNCI Cancer Spectrum|November 2, 2020
Establishing a Framework for the Clinical Translation of Germline Findings in Precision OncologyKatherine Dixon, Sean Young, Yaoqing Shen, et al.
The Lancet. Oncology|July 13, 2026
Switching to camizestrant at ESR1 mutation emergence before disease progression during first-line treatment of hormone receptor-positive advanced breast cancer (SERENA-6): extended analysis of a double-blind, placebo-controlled, randomised, phase 3 trialNicholas C Turner, Erica L Mayer, Yeon Hee Park, et al.
Cold Spring Harbor Molecular Case Studies|May 6, 2016
Lessons learned from the application of whole-genome analysis to the treatment of patients with advanced cancersJanessa Laskin, Steven Jones, Samuel Aparicio, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 7, 2020
Improved structural variant interpretation for hereditary cancer susceptibility using long-read sequencingMy Linh Thibodeau, Kieran O'Neill, Katherine Dixon, et al.
The New England Journal of Medicine|March 20, 2024
Ribociclib plus Endocrine Therapy in Early Breast CancerDennis Slamon, Oleg Lipatov, Zbigniew Nowecki, et al.
Clinical Breast Cancer|November 13, 2020
Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET TrialArlene Chan, Beverly Moy, Janine Mansi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2017
Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast CancerEric Y Zhao, Yaoqing Shen, Erin Pleasance, et al.
JAMA|April 2, 2024
Tumor-Infiltrating Lymphocytes in Triple-Negative Breast CancerRoberto A Leon-Ferre, Sarah Flora Jonas, Roberto Salgado, et al.
Pageof 11